PubMed Health⌕ Search

PubMed · 3064290

[Quinolones].

Abstract

New quinolones are notable for their high level of antibacterial activity, especially against gram-negative pathogens, and also for their specific pharmacokinetics involving good bioavailability after oral administration, high distribution volumes and a long elimination time. In view of these properties the more recent quinolones can be regarded as on a par with the modern beta-lactam antibiotics and aminoglycosides, which, especially through the possibility of oral administration in infections with problem organisms such as Pseudomonas aeruginosa or Serratia, represent a therapeutic advance. To maintain this advance the indications for therapy must be approached in a restrictive and critical spirit; the newer quinolones are only rarely the drugs of choice and should be held in reserve for complicated infections of the respiratory tract, the intestinal tract, the urinary tract and the bones. In regard to tolerance, particular consideration should be given to the specific CNS intolerance reaction.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Lode. 1988-12-10. [Quinolones].. https://pubmed.health/record/pubmed%3A3064290/quinolones

Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.

KEEP EXPLORING

Related citations

4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore modeling.

The 3-ethoxycarbonyl-4-quinolone compound 1 has previously been identified via a database search as an interesting lead compound for ligand binding at the benzodiazepine site of GABA(A) receptors (Kahnberg et al. J. Mol. Graphics Modelling 2004, 23, 253-261). Pharmacophore-guided optimization of this lead compound yielded a number of high-affinity ligands for the benzodiazepine site including compounds 20 and 23-25 displaying sub-nanomolar affinities. A few of the compounds have been tested on the alpha(1)beta(2)gamma(2S) and alpha(3)beta(2)gamma(2S) GABA(A) receptor subtypes, and two of the compounds (5 and 19) display selectivity for alpha(1)- versus alpha(3)-containing receptors by a factor of 22 and 27, respectively. This selectivity for alpha(1)beta(2)gamma(2S) is in the same range as that for the well-known alpha(1) subunit selective compound zolpidem.

4-Quinolones↗

4-quinolone signalling in Pseudomonas aeruginosa: old molecules, new perspectives.

In Pseudomonas aeruginosa, diverse virulence determinants and secondary metabolites are regulated via the action of a hierarchical quorum-sensing system which integrates two chemically distinct classes of signal molecules, the N-acylhomoserine lactones (AHLs) and the 4-quinolones (4Qs). Synthesis of the pseudomonas quinolone signal, 2-heptyl-3-hydroxy-4-quinolone (PQS) depends on the pqsABCDE locus which is responsible for generating multiple 4Qs including 2-heptyl-4-quinolone (HHQ), the immediate PQS precursor. Exported HHQ is taken up by adjacent bacterial cells and converted into PQS by PqsH, a putative mono-oxygenase. In addition, PQS regulates its own production by driving the expression of pqsABCDE through a direct interaction with PqsR (MvfR). PQS regulates diverse target genes including those coding for elastase, rhamnolipid, the PA-IL lectin and pyocyanin via the action of PqsE as well as influencing biofilm development and impacting on cellular fitness. Furthermore, 4Q signalling is not restricted to P. aeruginosa raising the possibility of cross-talk with other related bacterial species which occupy similar ecological niches.

4-Quinolones↗